ACCORD BP, INVEST, and blood pressure management in diabetics
This feature requires the newest version of Flash. You can download it here.


Results from ACCORD BP and the post hoc analysis of INVEST released here in Atlanta today show no advantage to aggressive lowering of systolic blood pressure in diabetic patients. How will these results change your BP goal for this subset of patients?

See:

ACCORD BP: Intensive BP lowering futile in diabetics

INVEST: Mortality hazard with lowest blood pressures in diabetics with CAD?